The investigators conducted semistructured phone interviews to recruit patients with bladder, prostate, or kidney cancer.
GU Cancer
Explore the most recent news and cutting-edge research in genitourinary (GU) cancer. Cancer Nursing Today reports on the latest clinical updates affecting the urinary tract and male reproductive system. Discover how the newest trials and research are changing the GU cancer care landscape for clinicians and patients.
Advertisement
Garg explained the importance of investigating disparities across racial and ethnic groups in the Hispanic community.
The open-label phase 2 clinical trial enrolled 33 patients with resectable, high-risk ccRCC.
Optimal management of non-clear cell renal cell carcinoma remains an unmet need.
While RCC is the leading cause of cancer-related mortality, early detection can greatly improve disease outcomes.
Researchers investigated if a frailty index could assess for associations between toxicity, clinical outcomes, and frailty.
Research is currently limited on how GLP-1 receptor agonists affect ICI efficacy in patients with cancer.
The phase 3 study is the longest follow-up—9 years—of a first-line checkpoint inhibitor combination in advanced RCC.
Researchers predicted that sMAdCAM-1 could be used as a prognostic biomarker in ICI-based therapy for patients with mRCC.
Patients with ccRCC were randomly selected to receive pembrolizumab or placebo and categorized by risk for metastasis.
Oncology social workers performed resource-intensive screening to assess distress in patients with gynecologic cancers.
Trending
Studying for certification tests can be intimidating. Here are some essential tips to help you do your best.
These tips are important resources for oncology nurses who are recent graduates and experienced nurses new to this specialty.
With the shift in cancer care to the ambulatory care setting, a dedicated oncology nurse educator is a key asset to nurses.
Gastroparesis occurs in 60% of patients with advanced pancreatic cancer, and is frequently overlooked in upper GI tumors.
More unique, non-traditional jobs are emerging for oncology nurses to consider outside traditional positions.
Alkaline phosphatase may serve as a discriminating marker in detecting bone lesions in patients with multiple myeloma.